Bosun Asset Management LLC purchased a new stake in Phreesia, Inc. (NYSE:PHR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 10,611 shares of the company's stock, valued at approximately $267,000.
A number of other institutional investors and hedge funds have also modified their holdings of PHR. Vanguard Group Inc. raised its holdings in Phreesia by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company's stock worth $121,349,000 after acquiring an additional 61,048 shares during the period. Greenhouse Funds LLLP increased its stake in shares of Phreesia by 27.9% in the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock worth $72,307,000 after purchasing an additional 626,579 shares during the period. Franklin Resources Inc. lifted its position in shares of Phreesia by 0.8% during the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock worth $37,982,000 after purchasing an additional 11,986 shares during the last quarter. Northern Trust Corp grew its holdings in Phreesia by 6.6% in the 4th quarter. Northern Trust Corp now owns 571,807 shares of the company's stock valued at $14,387,000 after buying an additional 35,392 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Phreesia by 10.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock valued at $12,415,000 after purchasing an additional 46,209 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.
Phreesia Trading Up 0.7 %
Shares of Phreesia stock traded up $0.19 on Friday, hitting $25.57. 867,739 shares of the company's stock traded hands, compared to its average volume of 435,606. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The firm's 50-day moving average price is $25.08 and its two-hundred day moving average price is $24.72. The stock has a market capitalization of $1.50 billion, a PE ratio of -17.39 and a beta of 0.74.
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. Needham & Company LLC restated a "buy" rating and set a $29.00 price target on shares of Phreesia in a research note on Thursday, March 13th. KeyCorp lowered their target price on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. DA Davidson cut their price target on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Piper Sandler reiterated an "overweight" rating and issued a $33.00 price objective (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Finally, Canaccord Genuity Group raised their target price on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of "Buy" and an average target price of $31.33.
Read Our Latest Report on PHR
Insider Activity at Phreesia
In other Phreesia news, CFO Balaji Gandhi sold 28,759 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $30.00, for a total value of $862,770.00. Following the completion of the transaction, the chief financial officer now directly owns 116,174 shares of the company's stock, valued at approximately $3,485,220. The trade was a 19.84 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the firm's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $29.72, for a total value of $103,901.12. Following the sale, the general counsel now directly owns 142,630 shares in the company, valued at approximately $4,238,963.60. This represents a 2.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 111,640 shares of company stock worth $3,094,167 in the last ninety days. Company insiders own 5.80% of the company's stock.
Phreesia Company Profile
(
Free Report)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Read More

Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.